Evidence map›Paper›PMID 24349369›Full record

ArticlePloS one2013

Effects of remifemin treatment on bone integrity and remodeling in rats with ovariectomy-induced osteoporosis.

Guangxia Cui, Huijie Leng, Ke Wang, Jianwei Wang, Sainan Zhu, Jing Jia, Xing Chen, Weiguang Zhang, Lihua Qin, Wenpei Bai

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Discovering the Untouched Perspective of Endangered North American HerbCombinatorial chemistry & high throughput screening · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Benefits of Black Cohosh (Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Guangxia CuiDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Huijie LengDepartment of Orthopaedics, Peking University Third Hospital, Beijing, China.
Ke WangDepartment of Anatomy and Embryology, Peking University Health Science Center, Beijing, China.
Jianwei WangDepartment of Anatomy and Embryology, Peking University Health Science Center, Beijing, China.
Sainan ZhuStatistics Office, Peking University First Hospital, Beijing, China.
Jing JiaDepartment of Stomatology, General Hospital of Armed Police, Beijing, China.
Xing ChenDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Weiguang ZhangDepartment of Anatomy and Embryology, Peking University Health Science Center, Beijing, China.
Lihua QinDepartment of Anatomy and Embryology, Peking University Health Science Center, Beijing, China.
Wenpei BaiDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
Peking University · CNPeking University First Hospital · CNChinese People's Armed Police General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to evaluate the effects of Remifemin (isopropanolic extract of Cimicifuga Racemosa) on postmenopausal osteoporosis. 120 female Sprague-Dawley rats were randomly assigned to four groups: sham surgery with vehicle, ovariectomy with vehicle, ovariectomy with estradiol valerate, or ovariectomy with Remifemin. Daily oral administrations of the vehicle, estradiol valerate, or Remifemin began 2 weeks after surgery and lasted to 4, 8, or 12 weeks. Ten rats in each group were sacrificed at each timestep with assessment of bone mineral density, trabecular bone structure, and biomechanical parameters of the femur and lumbar vertebra. Bone turnover markers were evaluated 12 weeks after surgery. Both drugs prevented bone density loss in the distal end of the femur and preserved the trabecular bone structure in both the lumbar vertebra and distal end of the femur following ovariectomy. Both drugs protected bone stiffness at the tested regions and reduced bone reabsorption in ovariectomized rats. The preventive effects of Remifemin against bone-loss can rival those of estradiol valerate if treatment duration is adequately extended. In conclusion, Remifemin may demonstrate equivalent effects to estradiol valerate in terms of preventing postmenopausal osteoporosis.

Indexed as

AnimalsBiomarkersBone and BonesBone DensityBone RemodelingCimicifugaDisease Models, AnimalFemaleOsteoporosisOvariectomyPlant ExtractsRadiographyRatsTime FactorsBiomarkersPlant ExtractsRemifemin

Identifiers

PMID24349369
PMCPMC3857312
OpenAlexW2082038528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.